End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.85 TWD | +15.69% | -30.48% | -54.26% |
Apr. 18 | UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 634M 19.45M | Sales 2023 | 649M 19.91M | Capitalization | 4.1B 126M |
---|---|---|---|---|---|
Net income 2022 | 47M 1.44M | Net income 2023 | - 0 | EV / Sales 2022 | 8.97 x |
Net Debt 2022 | 119M 3.65M | Net Debt 2023 | 124M 3.82M | EV / Sales 2023 | 6.51 x |
P/E ratio 2022 |
116
x | P/E ratio 2023 |
3,465
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 27.77% |
1 day | +15.69% | ||
1 week | -30.48% | ||
Current month | -43.59% | ||
1 month | -46.18% | ||
3 months | -52.33% | ||
6 months | -47.86% | ||
Current year | -54.26% |
Managers | Title | Age | Since |
---|---|---|---|
Chi Hsiang Chen
CEO | Chief Executive Officer | - | 18-10-02 |
Meng Han Hsu
DFI | Director of Finance/CFO | - | 16-04-10 |
Ying Yun Fan
ADM | Chief Administrative Officer | - | 15-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Hsiang Chen
CEO | Chief Executive Officer | - | 18-10-02 |
Ping-Ho Yan
BRD | Director/Board Member | - | - |
Pai Feng Wu
PRN | Corporate Officer/Principal | - | 14-07-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 15.85 | +15.69% | 2,792,125 |
24-04-24 | 13.7 | -1.79% | 2,649,284 |
24-04-23 | 13.95 | -11.99% | 7,921,550 |
24-04-22 | 15.85 | -16.80% | 3,165,588 |
24-04-19 | 19.05 | -16.45% | 3,504,091 |
End-of-day quote Taipei Exchange, April 24, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-54.26% | 57.46M | |
+24.50% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.28% | 233B | |
+5.55% | 201B | |
-10.02% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- 6562 Stock